A detailed history of Wellington Management Group LLP transactions in Novartis Ag stock. As of the latest transaction made, Wellington Management Group LLP holds 3,999,175 shares of NVS stock, worth $419 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,999,175
Previous 4,384,650 8.79%
Holding current value
$419 Million
Previous $467 Million 1.46%
% of portfolio
0.08%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$106.13 - $120.89 $40.9 Million - $46.6 Million
-385,475 Reduced 8.79%
3,999,175 $460 Million
Q2 2024

Aug 13, 2024

SELL
$92.57 - $107.37 $18.9 Million - $22 Million
-204,700 Reduced 4.46%
4,384,650 $467 Million
Q1 2024

May 15, 2024

BUY
$95.27 - $108.47 $437 Million - $498 Million
4,589,350 New
4,589,350 $444 Million
Q4 2023

Feb 12, 2024

BUY
$92.27 - $101.54 $438 Million - $482 Million
4,746,599 New
4,746,599 $479 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $5.69 Million - $6.31 Million
-60,036 Reduced 1.26%
4,691,916 $478 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $9.49 Million - $10.8 Million
-102,533 Reduced 2.11%
4,751,952 $480 Million
Q1 2023

May 12, 2023

BUY
$80.03 - $92.81 $6,242 - $7,239
78 Added 0.0%
4,854,485 $447 Million
Q4 2022

Feb 13, 2023

SELL
$75.55 - $92.52 $17.6 Million - $21.6 Million
-233,195 Reduced 4.58%
4,854,407 $440 Million
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $36 Million - $42.1 Million
482,080 Added 10.47%
5,087,602 $387 Million
Q2 2022

Aug 15, 2022

BUY
$80.52 - $93.75 $38.1 Million - $44.4 Million
473,587 Added 11.46%
4,605,522 $389 Million
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $2.84 Million - $3.22 Million
35,483 Added 0.87%
4,131,935 $363 Million
Q4 2021

Feb 11, 2022

SELL
$79.7 - $88.13 $9.44 Million - $10.4 Million
-118,480 Reduced 2.81%
4,096,452 $358 Million
Q3 2021

Nov 15, 2021

BUY
$81.78 - $95.14 $60.9 Million - $70.9 Million
745,157 Added 21.48%
4,214,932 $345 Million
Q2 2021

Aug 16, 2021

SELL
$85.24 - $94.15 $33.8 Million - $37.4 Million
-397,106 Reduced 10.27%
3,469,775 $317 Million
Q1 2021

May 17, 2021

BUY
$83.5 - $98.47 $37.1 Million - $43.7 Million
443,841 Added 12.97%
3,866,881 $331 Million
Q4 2020

Feb 12, 2021

BUY
$78.07 - $94.43 $41.4 Million - $50.1 Million
530,362 Added 18.33%
3,423,040 $323 Million
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $65.9 Million - $73 Million
-802,064 Reduced 21.71%
2,892,678 $252 Million
Q2 2020

Aug 14, 2020

BUY
$80.93 - $91.1 $49.9 Million - $56.2 Million
616,385 Added 20.02%
3,694,742 $323 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $19.7 Million - $27.6 Million
278,890 Added 9.96%
3,078,357 $254 Million
Q4 2019

Feb 11, 2020

BUY
$84.35 - $95.37 $236 Million - $267 Million
2,799,467 New
2,799,467 $265 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $225B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.